Back
Savara, Inc. 10K Form
Buy
61
SVRA
Savara, Inc.
Last Price:
$6.53
Seasonality Move:
33.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | SVRA/Savara, Inc. Quarterly |
| 2023-08-10 | 10Q | SVRA/Savara, Inc. Quarterly |
| 2023-05-15 | 10Q | SVRA/Savara, Inc. Quarterly |
| 2022-11-10 | 10Q | SVRA/Savara, Inc. Quarterly |
| 2022-08-11 | 10Q | SVRA/Savara, Inc. Quarterly |
| 2022-05-11 | 10Q | SVRA/Savara, Inc. Quarterly |
Receive SVRA News And Ratings
See the #1 stock for the next 7 days that we like better than SVRA
SVRA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-22.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.55 |
| Price / Book: | 14.01 |
Profitability
| EPS (TTM): | -0.53510 |
|---|---|
| Net Income (TTM): | $-115.6M |
| Gross Margin: | $-275K |
| Return on Equity: | -78.83% |
| Return on Assets: | -61.14% |
Savara, Inc. Earnings Forecast
Key Savara, Inc. Financial Ratios
-
Per Share Earnings over the last 25 years have been positive in 15 years.
Savara, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SVRA |
| CUSIP: | 805111 |
| Website: | savarapharma.com |
Debt
| Debt-to-Equity Ratio: | 0.32 |
|---|---|
| Current Ratio: | 7.65 |
| Quick Ratio: | 7.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SVRA Technical Analysis vs Fundamental Analysis
Buy
61
Savara, Inc. (SVRA)
is a Buy
Is Savara, Inc. a Buy or a Sell?
-
Savara, Inc. stock is rated a BuyThe current Savara, Inc. [SVRA] share price is $6.50. The Score for SVRA is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.